DAVID YUNZHI LI,JIABING WANG,ZHENFAN YANG,QINGBEI ZENG,XIAOLIN ZHANG
申请号：
PT14710620
公开号：
PT2964638T
申请日:
2014.03.05
申请国别(地区):
PT
年份:
2017
代理人:
摘要：
The invention relates to compounds of formula (I), or a pharmaceutically acceptable salt thereof: which possess inhibitory activity against activating mutant forms of EGFR, and are accordingly useful for their anti-cancer activity and in methods of treatment of the human or animal body. The invention also relates pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm-blooded animal such as man.
